Dr Hisao Ogawa of Kumamoto University, Japan reported at a press conference and a hot-line session at the European Society of Cardiology 2015 Congress. The 3-year results from the Trial Study ATTEMPT-CVD, and the article was simultaneously published in the European Journal of Preventive Cardiology. Antihypertensive treatment with the angiotensin II receptor blocker telmisartan improved the levels of two important biomarkers of cardiovascular and renal risk compared with treatment with non-ARB’s. Youtube Channel: https://www.youtube.com/user/drzulfiquar Facebook: https://www.facebook.com/drzulfiquarahmed Google+: https://plus.google.com/+ZulfiquarAhmed Website: http://www.drzulfiquar.com
The Antihypertensive drug good for your Heart, Brain & Kidneys
- Post author:
- Post published:May 28, 2021
- Post category:Uncategorized
- Post comments:0 Comments